Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
Product Unit Size | Cost | Quantity | Stock |
---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
Purity | ≥98% |
---|---|
Formula | C33H59N11O10 |
Formula Wt. | 769.90 |
Solubility | Soluble in water (2 mg/mL), acetonitrile. |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
DAT inhibitor.
Macrocyclic lactone avermectin; GABA antagonist...
CDK9 inhibitor.
MGMT inhibitor.
Imidazole; 14-α demethylase inhibitor, potenti...
beta-catenin inhibitor
Found in cruciferous vegetables.
Synthetic steroid; glucocorticoid agonist.
Peptide, bee venom toxin; SK2/3/4 K+ channel bl...
Triterpene saponin found in species of Panax.
5-HT1A agonist, α1-adrenergic antagonist.
c-Raf activator, tyrosine kinase inhibitor.
Mycotoxin produced by Aspergillus; actin polyme...
MEK1/2 and Raf inhibitor.
Lignin found in Sesamin indicum;
Triterpene saponin found in species of Panax. <...
Fluoroquinolone; bacterial DNA gyrase and helic...
Curcumin derivative.
A third-generation ALK inhibitor.
GABA-A agonist, NMDA antagonist, voltage-gated ...